Thu, Dec 18, 2014, 11:23 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ChromaDex Corporation Message Board

  • investora2z investora2z Mar 16, 2013 12:35 AM Flag

    Getting better

    Yesterday the stock made a good move. The volumes were double (217K) of the previous day's volume (113K). Now the 10 day average is significantly higher than the 3 month average. The increase has been accompanied with a significant rise in stock price. However, the $0.85 level has not been crossed and unless that happens, it will remain stuck in a range. Before that, the $0.80 level has to be taken out. CDXC has hit this level twice and retraced. Another interesting thing yesterday was that the stock closed at the high point of the day. A dip to $0.68 was quickly bought and from $0.72, the upward trend started. The next trading session will be crucial, and one should watch the volume and also whether it is able to close above $0.80. On the fundamental front, more news is expected. The declared closing date for the deal for BluScience sale to Nutri Sci is 31st March, and hence we can expect more information on that within the next two weeks. The deal is likely to help improve the balance sheet of CDXC by one time cash inflows and softer loans. Further, the expected regular stream of royalties are likely to give the company steady net inflows based on the sales achieved by Nutri Sci. Based on the distribution strengths of NutriSci, the market for BluScience may expand, and the initial success achieved by CDXC will be surpassed. Importantly, CDXC will make money in selling the raw material for BluScience (ingredient pterostilbene) to NutriSci. The total value of the deal has been put at $6M. This deal may be good for the long term prospects of the company. In addition, the company has recently purchased license from Washington University for uses of Nicotinamide Riboside (CDXC's other main product hope) in neuropathies caused by axon degeneration.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.905-0.005(-0.55%)Dec 18 1:49 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.